Notice of Closed Meeting

• Citation: 85 FR 47376
• Record Number: 2020-17094
• Published date: 05 August 2020
• Section: Notices
• Court: Centers For Disease Control And Prevention

Federal Register, Volume 85 Issue 151 (Wednesday, August 5, 2020)

[Federal Register Volume 85, Number 151 (Wednesday, August 5, 2020)]
                [Notices]
                [Page 47376]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-17094]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Centers for Disease Control and Prevention
                Notice of Closed Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                amended, notice is hereby given of the following meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended, and the Determination of the Director, Strategic
                Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
                pursuant to Public Law 92-463. The grant applications and the
                discussions could disclose confidential trade secrets or commercial
                property such as patentable material, and personal information
                concerning individuals associated with the grant applications, the
                disclosure of which would constitute a clearly unwarranted invasion of
                personal privacy.
                 Name of Committee: Disease, Disability, and Injury Prevention
                and Control Special Emphasis Panel (SEP)-PAR 18-812, NIOSH Member
                Conflict.
                 Date: October 27, 2020.
                 Time: 1:00 p.m.-5:00 p.m., EDT
                 Place: Teleconference.
                 Agenda: To review and evaluate grant applications.
                 For Further Information Contact: Michael Goldcamp, Ph.D.,
                Scientific Reviewer Officer, Office of Extramural Programs, CDC/
                NIOSH, 1095 Willowdale Road, Morgantown, WV 26506, Telephone: (304)
                285-5951, [email protected].
                 The Director, Strategic Business Initiatives Unit, Office of the
                Chief Operating Officer, Centers for Disease Control and Prevention,
                has been delegated the authority to sign Federal Register notices
                pertaining to announcements of meetings and other committee
                management activities, for both the Centers for Disease Control and
                Prevention and the Agency for Toxic Substances and Disease Registry.
                Kalwant Smagh,
                Director, Strategic Business Initiatives Unit, Office of the Chief
                Operating Officer, Centers for Disease Control and Prevention.
                [FR Doc. 2020-17094 Filed 8-4-20; 8:45 am]
                BILLING CODE 4163-18-P